ATXN2 and pancreatic adenocarcinoma: ATXN2 has been reported to be overexpressed in pancreatic adenocarcinoma (PAAD) tumor tissues, and overexpression of ATXN2 promotes PADD cell proliferation, migration, and invasion (Fang et al., 2021).